A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
A phase 2 trial of Mifamurtide and Ifosfamide in Osteosarcoma, run by University of Oxford, recorded as terminated on the registry.
Overview
A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS) is a phase 2 interventional study registered as NCT02441309 by University of Oxford, with 8 participants recorded, started 2014-10 and due to reach its primary completion in 2016-11-04. Interventions recorded: Mifamurtide, Ifosfamide. Conditions recorded: Osteosarcoma.
Linked to the drug Mifamurtide because the registry names it among its interventions and Osteosarcoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialMifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
Shares Mifamurtide, Osteosarcoma and the tag pipeline.
- TrialEvaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma
Shares Mifamurtide, Osteosarcoma and the tag pipeline.
- TrialLu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Shares Osteosarcoma and the tag pipeline.
- TrialCombination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Shares Osteosarcoma and the tag pipeline.
- TrialStudy to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Shares Osteosarcoma and the tag pipeline.
- TrialHigh Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
Shares Osteosarcoma and the tag pipeline.
- TrialStudy of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
Shares Ifosfamide and the tag pipeline.
- TrialWill Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
Shares Osteosarcoma and the tag pipeline.